Boston Scientific Corporation BSX
Quarterly report 2024-Q3
added 11-01-2024
Country |
USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
CEO |
Mr. Michael Mahoney |
Employees in the company |
36 000 |
Shares |
1.45 B |
Market Cap[1] |
$ 130 B |
EBITDA (LTM) |
$ 3.22 B |
P/E (LTM) |
68.54 |
P/S (LTM) |
7.73 |
EPS (LTM) |
1.22 |
Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.
Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.
The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.
The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.